Table 5 Comparison of antibiotic susceptibility between ESBL and non-ESBL producing isolates
Antibiotic | ESBL | Non ESBL | P value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S | I | R | S | I | R | ||||||||
% | N | % | N | % | N | % | N | % | N | % | N | ||
Amikacin | 82.5 | 137 | 0.6 | 1 | 16.9 | 28 | 80.7 | 126 | 5.8 | 9 | 13.5 | 21 | 0.02 |
Cephalexin | 13.8 | 23 | 0 | 0 | 86.1 | 143 | 53.2 | 83 | 0 | 0 | 46.7 | 73 | 0 |
Cefotaxime | 18.6 | 31 | 1.8 | 3 | 79.5 | 132 | 69.8 | 109 | 4.4 | 7 | 25.6 | 40 | 0 |
Ceftriaxone | 19.2 | 32 | 1.8 | 3 | 78.9 | 131 | 71.1 | 111 | 6.4 | 10 | 22.4 | 35 | 0 |
Ceftazidime | 19.2 | 32 | 1.2 | 2 | 79.5 | 132 | 73.07 | 114 | 11.5 | 18 | 15.3 | 24 | 0 |
Cefuroxime | 16.2 | 27 | 3.01 | 5 | 80.7 | 134 | 64.7 | 101 | 8.3 | 13 | 26.9 | 42 | 0 |
Co-trimoxazole | 19.2 | 32 | 1.2 | 2 | 79.5 | 132 | 37.1 | 58 | 5.1 | 8 | 57.6 | 90 | 0 |
Meropenem | 83.1 | 138 | 6.02 | 10 | 10.8 | 18 | 83.3 | 130 | 7.05 | 11 | 9.6 | 15 | 0.88 |
Ciprofloxacin | 52.4 | 87 | 9.03 | 15 | 38.5 | 64 | 76.2 | 119 | 7.6 | 12 | 16.02 | 25 | 0 |
Doxycycline | 24.6 | 41 | 6.6 | 11 | 68.6 | 114 | 42.9 | 67 | 9.6 | 15 | 47.4 | 74 | 0.001 |
Gentamicin | 56.02 | 93 | 5.4 | 9 | 38.5 | 64 | 66.02 | 103 | 5.1 | 8 | 28.8 | 45 | 0.16 |
Imipenem | 72.8 | 121 | 12.6 | 21 | 14.4 | 24 | 78.8 | 123 | 12.8 | 20 | 8.3 | 13 | 0.03 |
Amoxicillin/clauvanic acid | 28.3 | 47 | 18.07 | 30 | 53.6 | 89 | 44.8 | 70 | 10.8 | 17 | 44.2 | 69 | 0.006 |
Amoxicillin | 3.01 | 5 | 0 | 0 | 96.9 | 161 | 10.2 | 16 | 1.9 | 3 | 87.8 | 137 | 0.006 |